MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$103,121K
(-30.07%↓ Y/Y)
Deferred income tax
benefit
-$793K
(62.18%↑ Y/Y)
Net loss before
deferred income tax...
-$103,914K
(-27.70%↓ Y/Y)
Net gain (loss) from
discontinued operations
$514K
(154.16%↑ Y/Y)
Interest income
$8,114K
(-22.83%↓ Y/Y)
Other income from a
related party (note 3)
$1,400K
Net loss from
continuing operations
-$104,428K
(-29.84%↓ Y/Y)
Total non-operating
income, net
$9,136K
(-12.65%↓ Y/Y)
Interest and other
expense
$376K
Equity in loss of
affiliate
-$2K
(75.00%↑ Y/Y)
Operating loss
-$113,564K
(-24.95%↓ Y/Y)
Grant revenue
$884K
(-39.20%↓ Y/Y)
Total operating
expenses
$114,448K
(23.94%↑ Y/Y)
Research and development
$84,215K
(102.26%↑ Y/Y)
General and
administrative
$30,233K
(13.60%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Perspective Therapeutics, Inc. (CATX)
Perspective Therapeutics, Inc. (CATX)